Home

Diana Brainard, CEO: Kalaris Therapeutics KLRS Sell · Filed 23/05/19

Trade details

Type
Insider sale
Amount
$19,096.56
Shares · price
4,536 sh · $4.21 a share
Held after
916,628 sh
Trade date
23/05/18
Filed
23/05/19
Days to filing
1 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/18~23/06/17

Diana Brainard's recent trades

  • Diana Brainard

    SellKalaris Therapeutics

    $4,788

    Filed 24/11/20

  • Diana Brainard

    SellKalaris Therapeutics

    $9,124

    Filed 24/11/06

  • Diana Brainard

    SellKalaris Therapeutics

    $7,607

    Filed 24/10/23

  • Diana Brainard

    SellKalaris Therapeutics

    $1,209

    Filed 24/10/04

  • Diana Brainard

    SellKalaris Therapeutics

    $3,989

    Filed 24/08/22

Diana Brainard, CEO — sold $19.1K of Kalaris Therapeutics KLRS · 0.5% of holdings · 10b5-1 plan | Whalegun